[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PRRS Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

June 2024 | 132 pages | ID: G920CE3356CGEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global PRRS Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.

The Global Info Research report includes an overview of the development of the PRRS Vaccines industry chain, the market status of Government Tender (Live Vaccines, Killed Vaccines), Market Sales (Live Vaccines, Killed Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PRRS Vaccines.

Regionally, the report analyzes the PRRS Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PRRS Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the PRRS Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PRRS Vaccines industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Live Vaccines, Killed Vaccines).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PRRS Vaccines market.

Regional Analysis: The report involves examining the PRRS Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PRRS Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to PRRS Vaccines:

Company Analysis: Report covers individual PRRS Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PRRS Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Government Tender, Market Sales).

Technology Analysis: Report covers specific technologies relevant to PRRS Vaccines. It assesses the current state, advancements, and potential future developments in PRRS Vaccines areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PRRS Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

PRRS Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Live Vaccines
  • Killed Vaccines
Market segment by Application
  • Government Tender
  • Market Sales
Major players covered
  • CAHIC
  • Merial
  • MSD Animal Health
  • Chopper Biology
  • Ceva
  • ChengDu Tecbond
  • Veterinary
  • Ringpu Biology
  • Qilu Animal
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP
  • Tecon
  • Zoetis
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe PRRS Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of PRRS Vaccines, with price, sales, revenue and global market share of PRRS Vaccines from 2019 to 2024.

Chapter 3, the PRRS Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the PRRS Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PRRS Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of PRRS Vaccines.

Chapter 14 and 15, to describe PRRS Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of PRRS Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global PRRS Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Live Vaccines
  1.3.3 Killed Vaccines
1.4 Market Analysis by Application
  1.4.1 Overview: Global PRRS Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Government Tender
  1.4.3 Market Sales
1.5 Global PRRS Vaccines Market Size & Forecast
  1.5.1 Global PRRS Vaccines Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global PRRS Vaccines Sales Quantity (2019-2030)
  1.5.3 Global PRRS Vaccines Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 CAHIC
  2.1.1 CAHIC Details
  2.1.2 CAHIC Major Business
  2.1.3 CAHIC PRRS Vaccines Product and Services
  2.1.4 CAHIC PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 CAHIC Recent Developments/Updates
2.2 Merial
  2.2.1 Merial Details
  2.2.2 Merial Major Business
  2.2.3 Merial PRRS Vaccines Product and Services
  2.2.4 Merial PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Merial Recent Developments/Updates
2.3 MSD Animal Health
  2.3.1 MSD Animal Health Details
  2.3.2 MSD Animal Health Major Business
  2.3.3 MSD Animal Health PRRS Vaccines Product and Services
  2.3.4 MSD Animal Health PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 MSD Animal Health Recent Developments/Updates
2.4 Chopper Biology
  2.4.1 Chopper Biology Details
  2.4.2 Chopper Biology Major Business
  2.4.3 Chopper Biology PRRS Vaccines Product and Services
  2.4.4 Chopper Biology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Chopper Biology Recent Developments/Updates
2.5 Ceva
  2.5.1 Ceva Details
  2.5.2 Ceva Major Business
  2.5.3 Ceva PRRS Vaccines Product and Services
  2.5.4 Ceva PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Ceva Recent Developments/Updates
2.6 ChengDu Tecbond
  2.6.1 ChengDu Tecbond Details
  2.6.2 ChengDu Tecbond Major Business
  2.6.3 ChengDu Tecbond PRRS Vaccines Product and Services
  2.6.4 ChengDu Tecbond PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 ChengDu Tecbond Recent Developments/Updates
2.7 Veterinary
  2.7.1 Veterinary Details
  2.7.2 Veterinary Major Business
  2.7.3 Veterinary PRRS Vaccines Product and Services
  2.7.4 Veterinary PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Veterinary Recent Developments/Updates
2.8 Ringpu Biology
  2.8.1 Ringpu Biology Details
  2.8.2 Ringpu Biology Major Business
  2.8.3 Ringpu Biology PRRS Vaccines Product and Services
  2.8.4 Ringpu Biology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Ringpu Biology Recent Developments/Updates
2.9 Qilu Animal
  2.9.1 Qilu Animal Details
  2.9.2 Qilu Animal Major Business
  2.9.3 Qilu Animal PRRS Vaccines Product and Services
  2.9.4 Qilu Animal PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Qilu Animal Recent Developments/Updates
2.10 DHN
  2.10.1 DHN Details
  2.10.2 DHN Major Business
  2.10.3 DHN PRRS Vaccines Product and Services
  2.10.4 DHN PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 DHN Recent Developments/Updates
2.11 CAVAC
  2.11.1 CAVAC Details
  2.11.2 CAVAC Major Business
  2.11.3 CAVAC PRRS Vaccines Product and Services
  2.11.4 CAVAC PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 CAVAC Recent Developments/Updates
2.12 Komipharm
  2.12.1 Komipharm Details
  2.12.2 Komipharm Major Business
  2.12.3 Komipharm PRRS Vaccines Product and Services
  2.12.4 Komipharm PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Komipharm Recent Developments/Updates
2.13 Agrovet
  2.13.1 Agrovet Details
  2.13.2 Agrovet Major Business
  2.13.3 Agrovet PRRS Vaccines Product and Services
  2.13.4 Agrovet PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.13.5 Agrovet Recent Developments/Updates
2.14 Bioveta
  2.14.1 Bioveta Details
  2.14.2 Bioveta Major Business
  2.14.3 Bioveta PRRS Vaccines Product and Services
  2.14.4 Bioveta PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.14.5 Bioveta Recent Developments/Updates
2.15 Jinyu Bio-Technology
  2.15.1 Jinyu Bio-Technology Details
  2.15.2 Jinyu Bio-Technology Major Business
  2.15.3 Jinyu Bio-Technology PRRS Vaccines Product and Services
  2.15.4 Jinyu Bio-Technology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.15.5 Jinyu Bio-Technology Recent Developments/Updates
2.16 Institutul Pasteur
  2.16.1 Institutul Pasteur Details
  2.16.2 Institutul Pasteur Major Business
  2.16.3 Institutul Pasteur PRRS Vaccines Product and Services
  2.16.4 Institutul Pasteur PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.16.5 Institutul Pasteur Recent Developments/Updates
2.17 MVP
  2.17.1 MVP Details
  2.17.2 MVP Major Business
  2.17.3 MVP PRRS Vaccines Product and Services
  2.17.4 MVP PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.17.5 MVP Recent Developments/Updates
2.18 Tecon
  2.18.1 Tecon Details
  2.18.2 Tecon Major Business
  2.18.3 Tecon PRRS Vaccines Product and Services
  2.18.4 Tecon PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.18.5 Tecon Recent Developments/Updates
2.19 Zoetis
  2.19.1 Zoetis Details
  2.19.2 Zoetis Major Business
  2.19.3 Zoetis PRRS Vaccines Product and Services
  2.19.4 Zoetis PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.19.5 Zoetis Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: PRRS VACCINES BY MANUFACTURER

3.1 Global PRRS Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global PRRS Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global PRRS Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of PRRS Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 PRRS Vaccines Manufacturer Market Share in 2023
  3.4.2 Top 6 PRRS Vaccines Manufacturer Market Share in 2023
3.5 PRRS Vaccines Market: Overall Company Footprint Analysis
  3.5.1 PRRS Vaccines Market: Region Footprint
  3.5.2 PRRS Vaccines Market: Company Product Type Footprint
  3.5.3 PRRS Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global PRRS Vaccines Market Size by Region
  4.1.1 Global PRRS Vaccines Sales Quantity by Region (2019-2030)
  4.1.2 Global PRRS Vaccines Consumption Value by Region (2019-2030)
  4.1.3 Global PRRS Vaccines Average Price by Region (2019-2030)
4.2 North America PRRS Vaccines Consumption Value (2019-2030)
4.3 Europe PRRS Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific PRRS Vaccines Consumption Value (2019-2030)
4.5 South America PRRS Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa PRRS Vaccines Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global PRRS Vaccines Sales Quantity by Type (2019-2030)
5.2 Global PRRS Vaccines Consumption Value by Type (2019-2030)
5.3 Global PRRS Vaccines Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global PRRS Vaccines Sales Quantity by Application (2019-2030)
6.2 Global PRRS Vaccines Consumption Value by Application (2019-2030)
6.3 Global PRRS Vaccines Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America PRRS Vaccines Sales Quantity by Type (2019-2030)
7.2 North America PRRS Vaccines Sales Quantity by Application (2019-2030)
7.3 North America PRRS Vaccines Market Size by Country
  7.3.1 North America PRRS Vaccines Sales Quantity by Country (2019-2030)
  7.3.2 North America PRRS Vaccines Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe PRRS Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe PRRS Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe PRRS Vaccines Market Size by Country
  8.3.1 Europe PRRS Vaccines Sales Quantity by Country (2019-2030)
  8.3.2 Europe PRRS Vaccines Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific PRRS Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific PRRS Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific PRRS Vaccines Market Size by Region
  9.3.1 Asia-Pacific PRRS Vaccines Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific PRRS Vaccines Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America PRRS Vaccines Sales Quantity by Type (2019-2030)
10.2 South America PRRS Vaccines Sales Quantity by Application (2019-2030)
10.3 South America PRRS Vaccines Market Size by Country
  10.3.1 South America PRRS Vaccines Sales Quantity by Country (2019-2030)
  10.3.2 South America PRRS Vaccines Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa PRRS Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa PRRS Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa PRRS Vaccines Market Size by Country
  11.3.1 Middle East & Africa PRRS Vaccines Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa PRRS Vaccines Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 PRRS Vaccines Market Drivers
12.2 PRRS Vaccines Market Restraints
12.3 PRRS Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of PRRS Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of PRRS Vaccines
13.3 PRRS Vaccines Production Process
13.4 PRRS Vaccines Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 PRRS Vaccines Typical Distributors
14.3 PRRS Vaccines Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global PRRS Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global PRRS Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CAHIC Basic Information, Manufacturing Base and Competitors
Table 4. CAHIC Major Business
Table 5. CAHIC PRRS Vaccines Product and Services
Table 6. CAHIC PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CAHIC Recent Developments/Updates
Table 8. Merial Basic Information, Manufacturing Base and Competitors
Table 9. Merial Major Business
Table 10. Merial PRRS Vaccines Product and Services
Table 11. Merial PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merial Recent Developments/Updates
Table 13. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. MSD Animal Health Major Business
Table 15. MSD Animal Health PRRS Vaccines Product and Services
Table 16. MSD Animal Health PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. MSD Animal Health Recent Developments/Updates
Table 18. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 19. Chopper Biology Major Business
Table 20. Chopper Biology PRRS Vaccines Product and Services
Table 21. Chopper Biology PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Chopper Biology Recent Developments/Updates
Table 23. Ceva Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Major Business
Table 25. Ceva PRRS Vaccines Product and Services
Table 26. Ceva PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Ceva Recent Developments/Updates
Table 28. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 29. ChengDu Tecbond Major Business
Table 30. ChengDu Tecbond PRRS Vaccines Product and Services
Table 31. ChengDu Tecbond PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ChengDu Tecbond Recent Developments/Updates
Table 33. Veterinary Basic Information, Manufacturing Base and Competitors
Table 34. Veterinary Major Business
Table 35. Veterinary PRRS Vaccines Product and Services
Table 36. Veterinary PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Veterinary Recent Developments/Updates
Table 38. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 39. Ringpu Biology Major Business
Table 40. Ringpu Biology PRRS Vaccines Product and Services
Table 41. Ringpu Biology PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Ringpu Biology Recent Developments/Updates
Table 43. Qilu Animal Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Animal Major Business
Table 45. Qilu Animal PRRS Vaccines Product and Services
Table 46. Qilu Animal PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Qilu Animal Recent Developments/Updates
Table 48. DHN Basic Information, Manufacturing Base and Competitors
Table 49. DHN Major Business
Table 50. DHN PRRS Vaccines Product and Services
Table 51. DHN PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. DHN Recent Developments/Updates
Table 53. CAVAC Basic Information, Manufacturing Base and Competitors
Table 54. CAVAC Major Business
Table 55. CAVAC PRRS Vaccines Product and Services
Table 56. CAVAC PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. CAVAC Recent Developments/Updates
Table 58. Komipharm Basic Information, Manufacturing Base and Competitors
Table 59. Komipharm Major Business
Table 60. Komipharm PRRS Vaccines Product and Services
Table 61. Komipharm PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Komipharm Recent Developments/Updates
Table 63. Agrovet Basic Information, Manufacturing Base and Competitors
Table 64. Agrovet Major Business
Table 65. Agrovet PRRS Vaccines Product and Services
Table 66. Agrovet PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Agrovet Recent Developments/Updates
Table 68. Bioveta Basic Information, Manufacturing Base and Competitors
Table 69. Bioveta Major Business
Table 70. Bioveta PRRS Vaccines Product and Services
Table 71. Bioveta PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Bioveta Recent Developments/Updates
Table 73. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 74. Jinyu Bio-Technology Major Business
Table 75. Jinyu Bio-Technology PRRS Vaccines Product and Services
Table 76. Jinyu Bio-Technology PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Jinyu Bio-Technology Recent Developments/Updates
Table 78. Institutul Pasteur Basic Information, Manufacturing Base and Competitors
Table 79. Institutul Pasteur Major Business
Table 80. Institutul Pasteur PRRS Vaccines Product and Services
Table 81. Institutul Pasteur PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Institutul Pasteur Recent Developments/Updates
Table 83. MVP Basic Information, Manufacturing Base and Competitors
Table 84. MVP Major Business
Table 85. MVP PRRS Vaccines Product and Services
Table 86. MVP PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. MVP Recent Developments/Updates
Table 88. Tecon Basic Information, Manufacturing Base and Competitors
Table 89. Tecon Major Business
Table 90. Tecon PRRS Vaccines Product and Services
Table 91. Tecon PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Tecon Recent Developments/Updates
Table 93. Zoetis Basic Information, Manufacturing Base and Competitors
Table 94. Zoetis Major Business
Table 95. Zoetis PRRS Vaccines Product and Services
Table 96. Zoetis PRRS Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Zoetis Recent Developments/Updates
Table 98. Global PRRS Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 99. Global PRRS Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 100. Global PRRS Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 101. Market Position of Manufacturers in PRRS Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 102. Head Office and PRRS Vaccines Production Site of Key Manufacturer
Table 103. PRRS Vaccines Market: Company Product Type Footprint
Table 104. PRRS Vaccines Market: Company Product Application Footprint
Table 105. PRRS Vaccines New Market Entrants and Barriers to Market Entry
Table 106. PRRS Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global PRRS Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 108. Global PRRS Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 109. Global PRRS Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 110. Global PRRS Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 111. Global PRRS Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 112. Global PRRS Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 113. Global PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Global PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Global PRRS Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Global PRRS Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Global PRRS Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 118. Global PRRS Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 119. Global PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Global PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Global PRRS Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 122. Global PRRS Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 123. Global PRRS Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 124. Global PRRS Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 125. North America PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 126. North America PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 127. North America PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 128. North America PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 129. North America PRRS Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 130. North America PRRS Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 131. North America PRRS Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 132. North America PRRS Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Europe PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 134. Europe PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 135. Europe PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 136. Europe PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 137. Europe PRRS Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 138. Europe PRRS Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 139. Europe PRRS Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe PRRS Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 142. Asia-Pacific PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 143. Asia-Pacific PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 144. Asia-Pacific PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 145. Asia-Pacific PRRS Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 146. Asia-Pacific PRRS Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 147. Asia-Pacific PRRS Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 148. Asia-Pacific PRRS Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 149. South America PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 150. South America PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 151. South America PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 152. South America PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 153. South America PRRS Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 154. South America PRRS Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 155. South America PRRS Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 156. South America PRRS Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 157. Middle East & Africa PRRS Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 158. Middle East & Africa PRRS Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 159. Middle East & Africa PRRS Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 160. Middle East & Africa PRRS Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 161. Middle East & Africa PRRS Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 162. Middle East & Africa PRRS Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 163. Middle East & Africa PRRS Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 164. Middle East & Africa PRRS Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 165. PRRS Vaccines Raw Material
Table 166. Key Manufacturers of PRRS Vaccines Raw Materials
Table 167. PRRS Vaccines Typical Distributors
Table 168. PRRS Vaccines Typical Customers

LIST OF FIGURES

Figure 1. PRRS Vaccines Picture
Figure 2. Global PRRS Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global PRRS Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Live Vaccines Examples
Figure 5. Killed Vaccines Examples
Figure 6. Global PRRS Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global PRRS Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Government Tender Examples
Figure 9. Market Sales Examples
Figure 10. Global PRRS Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global PRRS Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global PRRS Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 13. Global PRRS Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 14. Global PRRS Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global PRRS Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of PRRS Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 PRRS Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 PRRS Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global PRRS Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global PRRS Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 21. North America PRRS Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe PRRS Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific PRRS Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. South America PRRS Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa PRRS Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Global PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global PRRS Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 28. Global PRRS Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global PRRS Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. Global PRRS Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America PRRS Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America PRRS Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 36. United States PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe PRRS Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe PRRS Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific PRRS Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific PRRS Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 52. China PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America PRRS Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America PRRS Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa PRRS Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa PRRS Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa PRRS Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa PRRS Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa PRRS Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. PRRS Vaccines Market Drivers
Figure 73. PRRS Vaccines Market Restraints
Figure 74. PRRS Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of PRRS Vaccines in 2023
Figure 77. Manufacturing Process Analysis of PRRS Vaccines
Figure 78. PRRS Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


More Publications